Tutku Aksoy

Tutku Aksoy

Auto-generated profile, based on publicly available information

Tutku Aksoy

Near East University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in Journal of Emergency Medicine Case Reports
Verified
Journal Article
Closed access
Buket BaddalBuket Baddal
Buket Baddal
ABAYSEGUL BOSTANCI
AYSEGUL BOSTANCI
TATutku Aksoy
Tutku Aksoy
YKYasemin Kucukciloglu
Yasemin Kucukciloglu
KSKaya Süer
Kaya Süer
Herpes simplex viruses (HSVs) belong to the Herpesviridae family. Close contact is the primary mode of transmission for both HSV-1 and HSV-2, leading to a persistent lifelong infection. HSVs are widely recognized as causative agents of viral infections affecting the central nervous system, capable of presenting as both meningitis and encephalitis. Herpes simplex virus type 1 (HSV-1) is the predominant viral cause of encephalitis, accounting for the majority of cases. Here, a rare co-infection case of meningoencephalitis, associated with HSV-1 and rickettsia is described. A 42-year-old man presenting with non-remitting headache for 6 days, fever, sweating, and muscle aches was admitted to the Emergency Department. His Weil-Felix test was positive for Proteus OX2 indicating rickettsial infection. Therapy started promptly however patient’s condition deteriorated. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis, and elevated protein concentration. CSF molecular analysis was positive for HSV-1. His cranial MRI indicated cytotoxic edema and gyral enhancement at the right temporal lobe. He was administered acyclovir for 14 days during hospital stay and was successfully discharged. This case report highlights that HSV-1 meningoencephalitis can co-occur with rickettsia infection in immunocompetent individuals, and co-infection with other agents should always be considered to avoid the progression of the disease.

30 April 2024 in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
Verified
Journal Article
Closed access
Buket BaddalBuket Baddal
Buket Baddal
BSBurcin Sanlidag
Burcin Sanlidag
TATutku Aksoy
Tutku Aksoy
YDYaren Doğramacıoğlu
Yaren Doğramacıoğlu
Enterovirus meningitis represents a common cause of meningitis worldwide. In this case study, a 5-year-old male with a travel history presenting with persistent nausea, vomiting, fever and headache for 3 days is reported. The patient described a fever of 39.5°C on the first day of symptom onset as well as decreased appetite and pain in the front right side of head. In physical examination, initially there was no sign of stiff neck, however he had neck stiffness the following day, Kernig's sign and Brudzinski's signs were positive. On admission, blood tests showed a slightly increased C-reactive protein and a normal white cell count. He was admitted to the pediatrics service and a lumbar puncture was performed. Intravenous ceftriaxone and acyclovir were empirically administered. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis, with normal protein and glucose concentration. CSF molecular analysis was positive for enterovirus RNA. Cranial magnetic resonance imaging with contrast was normal. Following confirmed diagnosis, ceftriaxone and acyclovir treatments were discontinued and he was given supportive care. He successfully recovered and was discharged without any complication. This case report highlights that rapid molecular testing favorably impacts patient management by improving antimicrobial stewardship through the reduction of intravenous therapy, side effects and inpatient bed-days.

28 April 2026 in Experimed
Verified
Journal Article
Closed access
Buket BaddalBuket Baddal
Buket Baddal
ABAYSEGUL BOSTANCI
AYSEGUL BOSTANCI
TATutku Aksoy
Tutku Aksoy
YDYaren Doğramacıoğlu
Yaren Doğramacıoğlu
Objective: Syndromic diagnostic testing is a relatively novel approach for the rapid diagnosis of central nervous system (CNS) infections. The aim of this study was to evaluate the rational use of the Food and Drug Administration (FDA)-approved meningitis/encephalitis panel for detecting CNS infections in critically ill patients.Materials and Methods: Cerebrospinal fluid (CSF) samples collected between December 2022 and December 2024 were analyzed using the QIAstat-Dx Meningitis/Encephalitis (QS-ME) panel kit. Patient demographics, clinical symptoms, and biochemical CSF parameters were retrospectively reviewed.Results: The study included 57 patients (34 male, 23 female) with a mean age of 48.9 ± 22.5 years. The overall positivity rate was 19.3% (n=11). Pathogens detected were varicella zoster virus (n=3), herpes simplex virus 1 (n=2), Streptococcus pneumoniae (n=2), Haemophilus influenzae (n=1), enterovirus (n=1), herpes simplex virus 2 (n=1), and human herpes virus 6 (n=1). The most frequent symptoms were headache and fever (54.5%, n=6), followed by loss of consciousness (45.5%, n=5), and vomiting (36.4%, n=4). Importantly, the positivity rates varied by department with 33.3% pediatrics, 30.0% infectious disease, 26.1% neurology, and 4.8% from the intensive care unit.Conclusion: To ensure cost effectiveness, QS-ME panel requests should be guided by clinical symptoms, biochemical CSF findings, and mandatory infectious disease consultation.